Bempedoic Acid: A Statin-Intolerance Savior? at AshTip Solution.

The US Food and Drug Administration has approved the anti-inflammatory drug colchicine 0.5 mg tablets (Lodoco) as the first specific anti-inflammatory drug demonstrated to reduce the risk for myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease. 2023-06-20

SAN DIEGO, CA – Orforglipron, Eli Lilly's investigational oral daily nonpeptide glucagon-like peptide-1 (GLP-1) agonist that can be taken with or without food, appears comparable with other injectable and oral agents in the class for treating obesity and type 2 diabetes, suggest two new phase 2 studies. 2023-06-24

Among patients with atrial fibrillation (AF) hospitalized for worsening heart failure (HF), catheter (cath) ablation within 90 days of admission compared with other times is associated with reduced risk for all-cause mortality and HF-related mortality. 2023-07-24